These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 5017549

  • 1. [Study of 30 parkinsonian patients treated for 6 months with L-Dopa].
    Barbizet J, Duizabo P.
    Therapie; 1972; 27(1):133-40. PubMed ID: 5017549
    [No Abstract] [Full Text] [Related]

  • 2. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa].
    Boudouresques J, Khalil R, Vigouroux RA, Gosset A, Daniel F, Dufour H.
    Mars Med; 1971; 108(2):85-9. PubMed ID: 5548385
    [No Abstract] [Full Text] [Related]

  • 3. [Case reports of some mental disorders in parkinsonian patients treated with L-dopa].
    Almici GM, Sbarbaro V.
    Minerva Med; 1974 Feb 03; 65(8):398-401. PubMed ID: 4820722
    [No Abstract] [Full Text] [Related]

  • 4. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD, Zilkha KJ, Knill-Jones RP, Clements PJ, Baxter R.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr 03; 4(3):356-60. PubMed ID: 4931417
    [No Abstract] [Full Text] [Related]

  • 5. External work of walking and functional capacity in Parkinsonian patients treated with L-dopa.
    Gersten JW, Marshall C, Dillon T, Schneck SA, Orr W, Nelson C.
    Arch Phys Med Rehabil; 1972 Dec 03; 53(12):547-53. PubMed ID: 4648427
    [No Abstract] [Full Text] [Related]

  • 6. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism].
    Dumas R, Rahme M, Schott B.
    J Med Lyon; 1971 Apr 20; 52(207):599-615. PubMed ID: 5136571
    [No Abstract] [Full Text] [Related]

  • 7. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
    Mones RJ, Elizan TS.
    J Mt Sinai Hosp N Y; 1969 Apr 20; 36(6):503-15. PubMed ID: 5261089
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. L-dopa and parkinsonism.
    Okihiro MM.
    Hawaii Med J; 1971 Apr 20; 30(5):390-2. PubMed ID: 5160226
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method].
    Okajima T, Kubota A, Nakahara N, Takeda S, Shimomura K.
    Naika; 1972 Apr 20; 29(2):335-43. PubMed ID: 4552443
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Action of L-dopa in Parkinson's syndrome].
    Ucar S, Eiras J.
    Rev Clin Esp; 1971 Feb 15; 120(3):257-62. PubMed ID: 5568474
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [L-dopa in Parkinson's syndrome].
    Filho RM, de Karam GM.
    Rev Bras Med; 1971 May 15; 28(5):220-31. PubMed ID: 5563096
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.